These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2947546)

  • 1. Effects of nicorandil on the rhythmic contractile response of isolated miniature pig coronary artery to 3,4-diaminopyridine: comparison with nitroglycerin.
    Kuromaru O; Sakai K
    Arch Int Pharmacodyn Ther; 1986 Oct; 283(2):272-81. PubMed ID: 2947546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of nicorandil on phasic contractions of isolated canine coronary artery.
    Uchida Y; Sugimoto T
    J Cardiovasc Pharmacol; 1987; 10 Suppl 8():S49-55. PubMed ID: 2447425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicorandil: differential contribution of K+ channel opening and guanylate cyclase stimulation to its vasorelaxant effects on various endothelin-1-contracted arterial preparations. Comparison to aprikalim (RP 52891) and nitroglycerin.
    Borg C; Mondot S; Mestre M; Cavero I
    J Pharmacol Exp Ther; 1991 Nov; 259(2):526-34. PubMed ID: 1682478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relaxant effect of nicorandil on the tonic contraction of the canine large coronary artery induced by phorbol 12,13-dibutylate.
    Kuromaru O; Sakai K
    Arch Int Pharmacodyn Ther; 1995; 330(1):25-38. PubMed ID: 8849308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a new antianginal agent, nicorandil, on normoxic and anoxic contractions in isolated miniature pig coronary arteries exposed to 5-hydroxytryptamine and norepinephrine: comparison with nitroglycerin and diltiazem.
    Nabata H; Sakai K
    Eur J Pharmacol; 1983 Dec; 96(1-2):37-44. PubMed ID: 6229411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of nicorandil on the conductive coronary artery of the dog.
    Imai S; Nakazawa M; Takeda K; Nakagawa Y; Katano Y; Tsukada T; Nabata H; Ushijima T
    J Cardiovasc Pharmacol; 1987; 10 Suppl 8():S10-6. PubMed ID: 2447415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a new antianginal agent, nicorandil, on the cardiovascular system of the miniature pig: with special reference to coronary vasospasm.
    Sakai K; Akima M; Shiraki Y; Hoshino E
    J Pharmacol Exp Ther; 1983 Oct; 227(1):220-8. PubMed ID: 6225867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abolition of spontaneous rhythmic contractions of isolated monkey coronary arteries by diltiazem, nifedipine, verapamil and nicorandil but not by nitroglycerin.
    Ishii K; Yanagisawa T; Satoh K; Taira N
    Tohoku J Exp Med; 1985 Jan; 145(1):85-90. PubMed ID: 3157242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of nicorandil on cytosolic calcium concentrations and on tension development in the rabbit femoral artery.
    Abe S; Nishimura J; Nakamura M; Kanaide H
    J Pharmacol Exp Ther; 1994 Feb; 268(2):762-71. PubMed ID: 8113988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relaxant effects of pinacidil, nicorandil, hydralazine and nifedipine as studied in the porcine coronary artery and guinea-pig taenia coli.
    Matsui K; Ogawa Y; Imai S
    Arch Int Pharmacodyn Ther; 1986 Sep; 283(1):124-33. PubMed ID: 2948465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the new nitrate ester ITF 296 on coronary and systemic hemodynamics in the conscious dog: comparison with nitroglycerin and nicorandil.
    Ueno A; Bergamaschi M; Gromo G; Nonaka K; Mizrahi J
    J Cardiovasc Pharmacol; 1995; 26 Suppl 4():S13-20. PubMed ID: 8839221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of nicorandil on coronary circulation in patients with ischemic heart disease: comparison with nitroglycerin.
    Aizawa T; Ogasawara K; Kato K
    J Cardiovasc Pharmacol; 1987; 10 Suppl 8():S123-9. PubMed ID: 2447419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dilator effects of nicorandil on isolated perfused coronary arteries of humans.
    Sakaino N; Araki H; Nishi K
    Arch Int Pharmacodyn Ther; 1990; 306():100-5. PubMed ID: 2150166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicorandil-induced vasorelaxation: functional evidence for K+ channel-dependent and cyclic GMP-dependent components in a single vascular preparation.
    Meisheri KD; Cipkus-Dubray LA; Hosner JM; Khan SA
    J Cardiovasc Pharmacol; 1991 Jun; 17(6):903-12. PubMed ID: 1714013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of relaxant effects of nicorandil on the dog coronary artery.
    Imai S; Ushijima T; Nakazawa M; Nabata H; Sakai K
    Arch Int Pharmacodyn Ther; 1983 Oct; 265(2):274-82. PubMed ID: 6228201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreasing potassium conductance--a possible mechanism of phasic coronary vasospasm.
    Uchida Y
    Jpn Circ J; 1985 Jan; 49(1):128-39. PubMed ID: 3155813
    [No Abstract]   [Full Text] [Related]  

  • 17. Contribution of cyclic GMP formation to KRN2391-induced relaxation in coronary artery of the pig.
    Jinno Y; Kasai H; Ohta H; Nishikori K; Fukushima H; Ogawa N
    Br J Pharmacol; 1992 Aug; 106(4):906-9. PubMed ID: 1327392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relaxing effect of nicorandil (N-2-(hydroxyethyl)-nicotinamide nitrate), a new anti-angina agent, on the isolated vascular smooth muscle.
    Shibata S; Satake N; Takagi T; Kerfoot F; Suh TK
    Eur J Pharmacol; 1984 Mar; 99(2-3):219-26. PubMed ID: 6234181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the anti-vasoconstrictor effects of a novel vasodilator KRN2391, nicorandil and nifedipine on isolated porcine large coronary artery.
    Kasai H; Jinno Y; Kaneta S; Tanaka Y; Fukushima H; Izawa T; Ogawa N
    Arch Int Pharmacodyn Ther; 1993; 321():63-71. PubMed ID: 8323417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The contribution of guanylate cyclase stimulation and K+ channel opening to nicorandil-induced vasorelaxation depends on the conduit vessel and on the nature of the spasmogen.
    Magnon M; Durand I; Cavero I
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1411-8. PubMed ID: 7908056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.